Sage Rhino Capital LLC Zoetis Inc. Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Sage Rhino Capital LLC holds 3,292 shares of ZTS stock, worth $537,616. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,292

Previous 3,428 3.97%

Holding current value

$537,616

Previous $594,000 8.25%

% of portfolio

0.15%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$172.58 - $196.48 $23,470 - $26,721	-136 Reduced 3.97%	3,292 $643,000
Q2 2024 Jul 30, 2024	BUY	$145.54 - $178.83 $2,765 - $3,397	19 Added 0.56%	3,428 $594,000
Q1 2024 Apr 26, 2024	SELL	$165.67 - $199.94 $26,672 - $32,190	-161 Reduced 4.51%	3,409 $576,000
Q4 2023 Feb 05, 2024	SELL	$151.44 - $200.09 $7,269 - $9,604	-48 Reduced 1.33%	3,570 $704,000
Q3 2023 Oct 26, 2023	SELL	$167.14 - $192.77 $4,512 - $5,204	-27 Reduced 0.74%	3,618 $629,000
Q2 2023 Jul 31, 2023	SELL	$160.94 - $186.23 $43,131 - $49,909	-268 Reduced 6.85%	3,645 $627,000
Q1 2023 Apr 20, 2023	BUY	$145.48 - $175.02 $46,553 - $56,006	320 Added 8.91%	3,913 $651,000
Q4 2022 Jan 31, 2023	BUY	$131.14 - $157.47 $14,425 - $17,321	110 Added 3.16%	3,593 $526,000
Q3 2022 Oct 24, 2022	BUY	$148.29 - $182.55 $14,532 - $17,889	98 Added 2.9%	3,483 $516,000
Q2 2022 Jul 28, 2022	BUY	$155.97 - $200.09 $22,303 - $28,612	143 Added 4.41%	3,385 $582,000
Q1 2022 Apr 27, 2022	SELL	$181.39 - $234.03 $143,298 - $184,883	-790 Reduced 19.59%	3,242 $611,000
Q4 2021 Feb 04, 2022	BUY	$193.69 - $247.03 $5,810 - $7,410	30 Added 0.75%	4,032 $984,000
Q3 2021 Oct 18, 2021	BUY	$189.29 - $209.69 $12,303 - $13,629	65 Added 1.65%	4,002 $777,000
Q2 2021 Jul 27, 2021	BUY	$155.9 - $187.99 $28,841 - $34,778	185 Added 4.93%	3,937 $734,000
Q1 2021 May 04, 2021	SELL	$144.0 - $169.39 $34,560 - $40,653	-240 Reduced 6.01%	3,752 $591,000
Q4 2020 Feb 03, 2021	BUY	$157.07 - $174.35 $1,570 - $1,743	10 Added 0.25%	3,992 $661,000
Q3 2020 Nov 05, 2020	SELL	$137.1 - $165.37 $3,701 - $4,464	-27 Reduced 0.67%	3,982 $659,000
Q2 2020 Jul 30, 2020	SELL	$111.92 - $142.53 $14,773 - $18,813	-132 Reduced 3.19%	4,009 $549,000
Q1 2020 Apr 29, 2020	SELL	$92.66 - $144.94 $21,497 - $33,626	-232 Reduced 5.31%	4,141 $487,000
Q4 2019 Jan 31, 2020	BUY	$116.25 - $133.25 $100,556 - $115,261	865 Added 24.66%	4,373 $593,000
Q3 2019 Oct 25, 2019	SELL	$112.57 - $128.43 $23,076 - $26,328	-205 Reduced 5.52%	3,508 $437,000
Q2 2019 Aug 20, 2019	SELL	$97.98 - $114.28 $26,650 - $31,084	-272 Reduced 6.83%	3,713 $421,000
Q1 2019 Apr 18, 2019	BUY	$81.56 - $100.67 $325,016 - $401,169	3,985 New	3,985 $401,000

Others Institutions Holding ZTS

# of Institutions

1,958

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Zoetis Inc. Transaction History